Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Impact of Zoledronic Acid and Denosumab Treatment on Growth Factor Concentration in Platelet Rich Fibrin of Patients With Osteolytic Bone Metastases
Daniel Steller, Ronja Simon, Robert Von Bialy, Samer G Hakim,
Ralph Pries
Clinic of Maxillofacial Surgery
Clinic of Otorhinolaryngology
Department of Maxillofacial Surgery
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Impact of Zoledronic Acid and Denosumab Treatment on Growth Factor Concentration in Platelet Rich Fibrin of Patients With Osteolytic Bone Metastases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Growth Factor
100%
Denosumab
100%
Bone Metastasis
100%
Zoledronic Acid
100%
Normal Human
30%
Osteoclast Differentiation Factor
30%
Jaw Osteonecrosis
20%
Wound Healing Impairment
20%
Drug
10%
Enzyme-Linked Immunosorbent Assay
10%
Vasculotropin
10%
Side Effect
10%
Wound Healing
10%
Platelet Derived Growth Factor BB
10%
Medicine and Dentistry
Bone Metastasis
100%
Zoledronic Acid
100%
Platelet-Rich Fibrin
100%
Denosumab
100%
Osteonecrosis of the Jaw
20%
Volunteer
20%
Wound Healing Impairment
20%
Wound Healing
10%
Side Effect
10%
In Vitro
10%
Vasculotropin
10%
Platelet Derived Growth Factor BB
10%
Drug
10%
Immunology and Microbiology
Growth Factor
100%
Denosumab
100%
Normal Human
30%
RANKL
30%
Jaw
20%
Wound Healing Impairment
20%
ELISA
10%
Platelet Derived Growth Factor BB
10%